DS
PRME icon

DRW Securities’s Prime Medicine PRME Stock Holding History

DRW Securities’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$143K Buy
+40,964
New +$156K ﹤0.01% 1159

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

DRW Securities's PRME Position: Q1 2026 in Review

DRW Securities opened a new position in Prime Medicine (PRME) in Q1 2026: 40,964 shares worth $143K. The stake represents ﹤0.01% of the portfolio and ranks #1159 among its holdings.

192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • DRW Securities held 40,964 shares of Prime Medicine worth $143K as of Q1 2026.
  • Prime Medicine was a new DRW Securities position in Q1 2026.
  • Prime Medicine made up ﹤0.01% of DRW Securities's portfolio in Q1 2026, its #1159 holding.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.